Skip to main content
. 2020 Aug 6;4(6):701–709. doi: 10.1002/ags3.12383

TABLE 1.

Clinicopathological characteristics of patients with PVT after hepatectomy

No PVT (n = 341) PVT (n = 57) P‐value
Age (y) 63.2 ± 13.3 (18‐90) 65.5 ± 8.7 (38‐83) .214
Sex, male 240 (70%) 41 (72%) .876
Diagnosis
HCC 157 (46%) 34 (60%) .063
ICC 18 (5%) 1 (2%) .497
Hilar cholangiocarcinoma 9 (3%) 0 (0%) .369
Metastatic 101 (30%) 15 (26%) .753
Other malignant 16 (5%) 2 (4%) 1.000
Living liver donor 15 (4%) 1 (2%) .487
Other benign 25 (7%) 4 (7%) 1.000
Patient's comorbidities
Hypertension 136 (40%) 20 (35%) .559
Cardiovascular disease 30 (9%) 5 (9%) 1.000
Cerebrovascular disease 15 (4%) 1 (2%) .487
Preoperative antithrombotic medication 46 (13%) 6 (11%) .673
Preoperative hemoglobin <12.0 g/dL 89 (26%) 14 (25%) .872
Preoperative platelet count <100 × 103/µL 26 (8%) 3 (5%) .783
Preoperative albumin <3.6 g/dL 73 (21%) 8 (14%) .285
Preoperative CRP >0.3 mg/dL 92 (27%) 13 (23%) .627
Preoperative PT activity <70% 17 (5%) 1 (2%) .490
BMI ≥25 kg/m2 94 (28%) 19 (33%) .428
ICG‐R15 >10%, n = 375 190 (56%) 39 (68%) .134
Child‐Pugh class A:B 326:15 56:1 .487
Surgical procedure
Partial resection 120 (35%) 10 (18%) .009
Subsegmentectomy 34 (10%) 13 (23%) .013
Segmentectomy 59 (17%) 14 (25%) .198
Bisegmentectomy 122 (36%) 20 (35%) 1.000
Trisegmentectomy 6 (2%) 0 (0%) .600
Laparoscopic surgery 31 (9%) 2 (4%) .200
Operation time (min) 456 ± 174 520 ± 206 .014
Blood loss (mL) 1142 ± 2256 1366 ± 3517 .527
Intraoperative RBC transfusion 98 (29%) 16 (28%) 1.000
Pringle's maneuver 276 (81%) 49 (86%) .461
Total:Selective 201:75 29:20 .061
Pringle time (min) 88 ± 54 128 ± 77 <.001
Resected liver weight (g) 383 ± 515 430 ± 348 .509
Postoperative bile leakage grade B/C 27 (8%) 9 (16%) .076
Histological liver cirrhosis, F4 stage 40 (12%) 7 (12%) .828

Continuous variables were expressed as mean ± SD.

Abbreviations: BMI, body mass index; HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; ICG‐R15, indocyanine green retention test after 15 min; PVT, portal vein thrombosis.